Wall Street is where money is made and lost. Financial guru Paul Mampilly worked on Wall Street for 20 plus years and was very successful. Now he’s on to greener pastures with his investment newsletter called Profits Unlimited. It all happened several years ago when he joined independent publishing firm Banyan Hill Publishing. Since then, it has grown tremendously gaining over 90,000 subscribers.Paul Mampilly has lots of great information, best investment tips, and recommendations in his newsletter that have helped people tremendously. Financial gains regularly are at two to three digits with a lot of happy subscribers on the other end. Since Paul watches the trends, he knows what is good to invest in and what is not.

The latest recommendations is precision medicine. This rapidly growing industry is going to change the face of medicine and how we look treatment. Paul Mampilly described that in the history of our world, it is going to be the biggest breakthrough in the medical industry. What is precision medicine exactly? It is exactly what is says, it’s medical treatment that is precise. To break it down even further, doctors will be able to use each individual’s DNA to diagnose, prevent, and treat patients more accurately than ever.This will certainly extent people lives and so much more. Doctors will be able to see everything about patient’s history, including their family’s, and their DNA to care for them properly.

Paul Mampilly worked on Wall Street for over 20 years, but he also attended university back in his youth. He earned a Master of Business Administration degree in finance from the Fordham Graduate School of Business.Mr. Mampilly previously attended Montclair State University where he achieved a Bachelor of Business Administration degree in accounting and finance.When it comes to financial institutions that Paul Mampilly worked for on Wall Street, there was many. He worked at Kinetics Asset Management to effortlessly manage their hedge fund. With precision and masterful technique, Paul grew it into a $25 billion dollar fund. He also worked for ING and Deutsche Bank in the beginning of his career. During his working career, Paul has gained the respect from the financial community.

Sources of the article : https://www.bloomberg.com/research/stocks/private/person.asp?personId=49260032&privcapId=109183793